Daily Ards Research Analysis
Three studies advance ARDS science across prognosis and risk stratification. A multicenter cohort links corrected minute ventilation (VEcorr) to mortality in COVID-19 ARDS, a single-center cohort identifies serum MRP8/14 as a strong prognostic biomarker in sepsis-induced pulmonary ARDS, and a systematic review/meta-analysis shows higher bronchoscopic grades of smoke inhalation injury associate with increased ARDS and pneumonia.
Summary
Three studies advance ARDS science across prognosis and risk stratification. A multicenter cohort links corrected minute ventilation (VEcorr) to mortality in COVID-19 ARDS, a single-center cohort identifies serum MRP8/14 as a strong prognostic biomarker in sepsis-induced pulmonary ARDS, and a systematic review/meta-analysis shows higher bronchoscopic grades of smoke inhalation injury associate with increased ARDS and pneumonia.
Research Themes
- Prognostic biomarkers and physiologic indices in ARDS
- Dead space ventilation and respiratory mechanics
- Bronchoscopic grading and outcomes in smoke inhalation injury
Selected Articles
1. Evaluating the association between bronchoscopic severity of burns-related smoke inhalation injury and clinical outcomes: A systematic review and meta-analysis.
Across 30 studies (12 meta-analyzed), higher bronchoscopic grades (AIS 3–4) of smoke inhalation injury were significantly associated with increased risks of pneumonia and ARDS compared with milder grades (AIS 1–2). Mortality trended higher but was not statistically significant. Substantial heterogeneity and variable grading systems limit certainty and highlight the need for standardized bronchoscopic classification.
Impact: This meta-analysis synthesizes the prognostic value of bronchoscopic severity grading in smoke inhalation injury, directly linking higher grades to ARDS and pneumonia. It provides an evidence base to refine early risk stratification in burn patients.
Clinical Implications: Patients with higher bronchoscopic grades should be considered high risk for ARDS and pneumonia, prompting early lung-protective ventilation, aggressive pulmonary hygiene, and closer monitoring. Adoption of standardized grading and integration with objective parameters could improve triage and clinical decision-making.
Key Findings
- Higher BII grades (AIS 3–4) were associated with increased pneumonia risk (RD 0.319, 95% CI 0.020–0.618, p=0.037).
- Higher BII grades were associated with increased ARDS risk (RD 0.242, 95% CI 0.118–0.367, p<0.001).
- Mortality was higher but not statistically significant for AIS 3–4 vs 1–2 (RD 0.068, 95% CI -0.017–0.153, p=0.116).
Methodological Strengths
- PRISMA-guided systematic search with quantitative synthesis
- Random-effects meta-analyses and exploration of alternative grading systems
Limitations
- High heterogeneity and inconsistent bronchoscopic grading systems across studies
- Limited number of studies contributing to each meta-analyzed outcome and potential publication bias
Future Directions: Standardize bronchoscopic grading and integrate objective clinical/physiologic parameters to refine risk models; develop prospective registries to validate thresholds predicting ARDS and pneumonia.
BACKGROUND: One-third of major burns are complicated by burns-related smoke inhalation injury (BII), which increases mortality risk. Fibreoptic bronchoscopy is the gold standard for BII diagnosis, with the Abbreviated Injury Score (AIS) being the most widely used grading system. While BII severity has been linked to poorer outcomes, this is the first systematic review and meta-analysis evaluating the association between bronchoscopic grading of BII and mortality, pneumonia, and acute respi
2. Impact of Corrected Minute Ventilation on Mortality in Mechanically Ventilated Patients With COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Observational Study Using the J-RECOVER Registry Data.
Among 335 invasively ventilated COVID-19 ARDS patients, higher VEcorr independently predicted in-hospital mortality (OR 1.11 per unit; 95% CI 1.01–1.23; p=0.039). Elevated VEcorr correlated with higher fibrin degradation products and FIB-4 scores, supporting links between dead space, coagulopathy, and hepatic fibrosis markers.
Impact: Provides multicenter evidence that a simple physiologic index (VEcorr) captures prognostic dead space burden in ARDS and links to extrapulmonary biology, informing bedside risk stratification.
Clinical Implications: Incorporating VEcorr into early assessment may help identify high-risk ARDS patients for intensified monitoring and tailored ventilatory strategies targeting dead space. Associations with coagulopathy suggest potential adjunctive paths for phenotyping and therapy.
Key Findings
- Higher VEcorr independently associated with increased in-hospital mortality (OR 1.11; 95% CI 1.01–1.23; p=0.039).
- Elevated VEcorr correlated with higher fibrin degradation products and FIB-4 scores.
- Association of higher VEcorr with elevated PaCO2 indicators of ventilatory inefficiency (as reported).
Methodological Strengths
- Multicenter registry cohort with standardized ventilator and ABG data at initiation
- Multivariable logistic regression adjusting for confounders
Limitations
- Observational design with potential residual confounding and selection bias
- VEcorr derived from initial settings; lack of longitudinal trajectories or external validation
Future Directions: Prospective validation of VEcorr thresholds and integration with dead-space-targeted ventilatory strategies; mechanistic studies linking dead space, coagulopathy, and outcomes.
Background Corrected minute ventilation (VEcorr) has been proposed as a surrogate marker for dead space ventilation and may be associated with increased mortality in COVID-19-related acute respiratory distress syndrome (ARDS). However, prior studies have shown inconsistent results, and the mechanisms contributing to elevated VEcorr remain unclear. Methodology A multicenter, observational study was conducted using data from the J-RECOVER registry, including 335 adult patients with COVID-19-rela
3. Prognostic significance of serum Mrp 8/14 in acute respiratory distress syndrome induced by pulmonary and extrapulmonary sepsis: A retrospective controlled study.
At ICU admission, serum MRP8/14 was higher in pulmonary ARDS than extrapulmonary ARDS and independently associated with ICU mortality in pulmonary ARDS (OR 1.223; 95% CI 1.105–1.375). MRP8/14 showed strong prognostic discrimination for ICU mortality (AUC 0.872), with a survival advantage below a threshold of 19.23 μg/mL.
Impact: Identifies a readily measurable biomarker with high prognostic accuracy specifically in sepsis-induced pulmonary ARDS, enabling early risk stratification.
Clinical Implications: Serum MRP8/14 at ICU admission could inform early prognostic assessment and triage in pulmonary sepsis-induced ARDS, guiding monitoring intensity and potentially enrollment in biomarker-enriched trials.
Key Findings
- Serum MRP8/14 higher in pulmonary ARDS vs extrapulmonary ARDS: median 15.91 vs 9.51 μg/mL (p=0.000).
- Independent association with ICU mortality in pulmonary ARDS (OR 1.223; 95% CI 1.105–1.375; p=0.000).
- Strong discrimination for ICU mortality: AUC 0.872 (95% CI 0.798–0.947); survival higher below 19.23 μg/mL (HR 3.480; 95% CI 1.819–6.659).
Methodological Strengths
- Clear stratification by ARDS origin (pulmonary vs extrapulmonary)
- Multivariable logistic regression and ROC analysis with threshold identification
Limitations
- Single-center retrospective design limits generalizability
- Biomarker measured at a single time point; external validation lacking
Future Directions: Prospective, multicenter validation and assessment of serial MRP8/14 dynamics; combine with clinical scores to build integrated prognostic models.
BACKGROUND: To date, it remains unclear whether serum Mrp 8/14 is differentially expressed in sepsis-induced ARDS patients of pulmonary and extrapulmonary origin during ICU hospitalization. This study investigated the association between serum Mrp 8/14 and clinical outcomes in sepsis-induced ARDS patients. METHODS: A retrospective, single-center cohort study was conducted involving 153 septic patients who developed ARDS during their ICU stay, resulting from either pulmonary or extrapulmonary i